| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 106,632,000 | 101,703,000 | 92,977,000 | | Cost of Revenue | 101,254,000 | 96,694,000 | 88,645,000 | | | Gross Profit | 5,378,000 | 5,009,000 | 4,332,000 | | | Operating Expenses | | Research Development | 364,000 | 347,000 | 284,000 | | Selling General and Administrative | 3,325,000 | 3,189,000 | 2,790,000 | | Non Recurring | 493,000 | (5,000) | (6,000) | | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 1,196,000 | 1,478,000 | 1,264,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 5,000 | 100,000 | 132,000 | | Earnings Before Interest And Taxes | 1,208,000 | 1,599,000 | 1,396,000 | | Interest Expense | 144,000 | 142,000 | 99,000 | | Income Before Tax | 1,064,000 | 1,457,000 | 1,297,000 | | Income Tax Expense | 241,000 | 468,000 | 329,000 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 823,000 | 989,000 | 968,000 | | | Non-recurring Events | | Discontinued Operations |
-
| 1,000 | (55,000) | | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 823,000 | 990,000 | 913,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $823,000 | $990,000 | $913,000 |
|
1.48% Nasdaq 
Income Statement
